ALPHA TRIBE

Neogen Chemicals LimitedInvestor Meet, 09-02-2025: Analysts/Institutional Investor Meet/Con. Call Updates

09-02-2025 | 10:58 pm

**Financial Performance:** Neogen Chemicals reported strong Q3 FY25 results with revenues of ₹201 crore, representing a 22% increase year-over-year. The company achieved an impressive 71% growth in EBITDA to ₹34.6 crore, largely due to improved plant utilization and operational efficiencies. Profit After Tax reached ₹10 crore, driven by robust operational performance and favorable base effects. Organic revenue grew by 36% to ₹177 crore, despite a 29% decline in inorganic revenue due to falling raw material prices.

**Future Outlook and Growth Drivers:** Management provided an optimistic outlook, targeting standalone revenues of ₹950 to ₹1,000 crore for FY26, supported by expanding lithium and electrolyte capacities and ongoing demand from battery manufacturers and other end-use sectors. Recent regulatory approvals, including the merger with BuLi Chemicals, are expected to enhance operational efficiency and market positioning.

**Order Book and Operational Updates:** Key operational highlights included successful trials for new product launches, with exports to Europe, Korea, and Japan beginning for BuLi Chemicals. A brownfield expansion has been approved, set to increase production capacity further. The company anticipates commencing commercial production at its new Greenfield facility by FY26.

**Analyst Q&A Insights (Detailed):** Analysts raised concerns about profitability amidst declining raw material prices and operational challenges related to quality control in electrolyte production. Management reassured that their pricing strategy has built-in mechanisms to mitigate volatility. The competitive landscape was discussed, with management highlighting ongoing efforts to localize production, sufficient inventory levels, and emerging opportunities in the domestic battery market.

**Market or Regulatory Updates:** Government support for electric vehicles and battery production continues to create a favorable environment for growth. The budget provisions aimed at boosting domestic manufacturing further bolster the company's strategy.

**Strategic Focus Areas:** Neogen's strategic focus remains on innovation, market expansion, and diversifying revenue streams in response to shifting demand. The company appears well-positioned to leverage emerging trends in lithium and battery materials.

**Investor Insight:** Given Neogen Chemicals' robust financial health, strong growth driver and strategic positioning, there is potential for a favorable investment outlook, suggesting a 'buy' stance for retail investors. The responses during the analyst Q&A indicated confidence in overcoming near-term challenges while capitalizing on long-term growth opportunities.

No comments yet. Be the first to comment!

All announcements from Neogen Chemicals Limited